Long COVID
Commentary
COVID can mimic prostate cancer symptoms
“I had none of those previously reported experiences that could suddenly trigger a spike in PSA.”
Feature
‘Breakthrough’ study: Diabetes drug helps prevent long COVID
Metformin led to a 42% drop in long COVID among people who had a mild to moderate COVID-19 infection.
From the Journals
Is cellular senescence related to post–COVID-19 syndrome?
Patients with a diagnosis of clinical aspects associated with PASC at 6 months were characterized by certain predisposing factors.
Conference Coverage
Metformin linked to reductions in COVID-19 viral load
Key questions the findings raise include whether the results correlate with clinical outcomes or transmission, and whether the findings are...
Feature
Inflammation and immunity troubles top long-COVID suspect list
“I think that it’s a much more complex picture than just inflammation, or just autoimmunity, or just immune dysregulation,” says expert.
News
Major life stressors ‘strongly predictive’ of long COVID symptoms
Therapies that lessen the trauma of the most stress-inducing life events need to be a central part of treatment for long COVID, with more research...
News
‘A huge deal’: Millions have long COVID, and more are expected
More than a quarter say their condition is severe enough to significantly limit their day-to-day activities.
Conference Coverage
Thyroid dysfunction may linger a year after severe COVID-19
The implications of the atypical thyroiditis areas, which tend to be asymptomatic, are unclear.
Commentary
I’m a physician battling long COVID. I can assure you it’s real
“I’ve also seen, firsthand, the frustration of navigating diagnosis and treatment. It’s given me a taste of what millions of other patients are...
Feature
For many, long COVID’s impacts go on and on, major study says
“This infection has become so common in a community because it’s so mild and spreading so rapidly that we’re seeing more long COVID symptoms than...
From the Journals
63% of long COVID patients are women, study says
The global study also found that about 6% of people with symptomatic infections had long COVID in 2020 and 2021.